Effect of Very Low-Dose Hydrocortisone on Shock Reversal in Patients With Septic Shock.
Ontology highlight
ABSTRACT: In patients with septic shock, hydrocortisone 200-400 mg/d has been shown to reverse shock compared with placebo. Lower doses of hydrocortisone have not previously been studied, and there are no previous studies comparing two different doses of hydrocortisone. At our institution, some clinicians routinely prescribe doses less than 200 mg/d. This study aims to compare the effect of lower doses of hydrocortisone to standard doses on shock reversal and adverse events in septic shock.Design
Retrospective cohort study.Setting
Single-center medical ICU.Subjects
Patients who received hydrocortisone for septic shock.Interventions
Electronic chart review.Measurements and main results
Patients were divided into low-dose hydrocortisone (75-150 mg/d) and standar
SUBMITTER: Sbertoli R
PROVIDER: S-EPMC7188423 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA